North Dakota Medical Marijuana Measure 5 Results: Live Updates

North Dakota’s Measure 5 would create a medical cannabis program for patients suffering from “debilitating medical conditions” — including in this case cancer and it’s treatments; HIV/AIDS; Hepatitis C; ALS or Lou Gehrig’s disease; post-traumatic stress disorder; Alzheimer’s disease, dementia and its treatments; Crohn’s disease, fibromyalgia; spinal damage/stenosis; chronic back pain; glaucoma; epilepsy; neuropathy; and wasting syndrome. The North Dakota Health Department would be able to add conditions after the fact, and citizens would be permitted to petition for condition approval under the program.


Update 11:04 pm EST – North Dakota voters have approved Measure 5 to legalize medicinal marijuana, according to numbers from the Associated Press via Google’s Election Tracker.

Update 10:34 pm EST – The gap has widened to 62-38 in favor of Measure 5 with 55 percent of precincts reporting, according to the Associated Press via Google’s Election Tracker.

Update 9:50 pm EST – The Associated Press via Google’s Election Tracker reports 60 percent to 40 percent in support of Measure 5 with 20 percent of precincts reporting.

Update 9:20 pm EST – The Associated Press via Google’s Election Tracker reports voting on Measure 5 is, so far, close at 54 percent to 46 percent in favor with 6 percent of precincts reporting.

Stay tuned to this article to learn more about North Dakota’s MMJ election results as the day carries on — we will be making updates as the news breaks.


Taxes: There are no tax implications.

Fees: $25,000 license fees following Health Department approval.

Revenue disbursement: A Compassionate Care Fund will be created, comprised of donations, fees, and civil penalties imposed.

VIDEO: Overview of Cannabis Initiatives

Below is a brief overview of all the different state-level cannabis initiatives on the ballot this election cycle. With nine total states voting on expanding access to cannabis, this year presents an unprecedented opportunity for legalization advocates and medical cannabis patients.

End